Ligand validation:2IXJ

SRT: S,R MESO-TARTARIC ACID

SRT is a Ligand Of Interest in 2IXJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2IXJ_SRT_A_1185	36%	16%	0.214	0.906	1.81	1.9	2	4	2	0	100%	1
1RTV_SRT_A_182	40%	18%	0.199	0.912	1.42	2.09	2	5	1	2	100%	1
2IXI_SRT_A_1183	7%	42%	0.234	0.696	1.08	1.17	-	1	1	0	100%	1
5MJG_SRT_A_301	97%	37%	0.068	0.981	1.02	1.44	-	2	1	0	100%	1
7F81_SRT_D_408	94%	39%	0.069	0.968	0.86	1.49	-	2	0	1	100%	1
2XB4_SRT_A_1225	90%	3%	0.085	0.969	2.2	4.12	2	4	0	1	100%	1
2VU7_SRT_A_1208	90%	37%	0.098	0.981	1.31	1.17	1	1	0	0	100%	1
4ADM_SRT_C_1466	88%	25%	0.085	0.962	1.57	1.49	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.